Clinical Trial Update: A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Imrecoxib in knee osteoarthritis; current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Imrecoxib (Imrecoxib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 4 | Status: UNKNOWN